Navigating Trade Challenges: How CSI Supports Your Clinical Trials

Recent headlines around proposed US tariffs on European countries highlight just how volatile the global trade environment remains. As reported this week in Fierce Pharma, potential new duties on several European nations raised questions about the future of US–EU trade relations and potential impacts on pharmaceuticals.

For sponsors running global clinical trials, this kind of uncertainty can translate into real operational risk: fluctuating costs, sourcing delays, and regulatory complexity across borders. That’s where Clinical Services International (CSI) comes in.

CSI supports clinical trial studies by providing robust, flexible comparator and ancillary sourcing strategies, designed to withstand geopolitical and trade disruptions. With direct relationships across global manufacturers and experience operating through our UK, EU, and US entities, we help sponsors mitigate tariff exposure, maintain compliant supply chains, and protect study timelines; even when policies shift unexpectedly.

In an environment where trade frameworks and import duties can change rapidly, having a trusted, globally experienced supply partner is critical. CSI helps ensure your clinical trials stay on track, no matter how complex the global landscape becomes.

Contact CSI now with your study requirements

Contact Us